In conclusion, we identified 24 metabolic genes associated with TP53 mutations and defined them as metabolic gene profiles, which are conducive to a deeper understanding of metabolic pathway changes caused by TP53 mutations and provide therapeutic targets for targeted metabolic pathways for BC patients with TP3 mutations. This evidence concerns the gene TP53 and breast cancer.